Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
12-year-olds
10%
A(H1N1)
100%
A(H1N1)pdm09 Influenza Virus
100%
A/H1N1 Virus
20%
After childhood
100%
Age-dependent
20%
Age-independent
10%
Antibody Landscape
20%
Antibody Profile
10%
Antibody Response
100%
Antigenic Change
50%
Antigenic Profile
10%
Antigenic Variant
30%
Antigenicity
10%
Birth Cohort
10%
Childhood Infections
100%
Correlates of Protection
10%
Cross-reactive Antibodies
10%
First Decade
10%
Hemagglutination Inhibition
20%
Hemagglutination Inhibition Antibody
40%
Hemagglutinin
100%
Hemagglutinin Protein
20%
Hemagglutinin-neuraminidase
20%
Immune Imprinting
10%
Immune Selection
10%
Influenza A(H1N1)pdm09 Virus
30%
Influenza Vaccine
10%
Influenza Virus Infection
10%
Licensure
10%
Neuraminidase
90%
Neuraminidase Inhibitors
100%
Neuraminidase Protein
50%
Seasonal Influenza Vaccine
30%
Selection Pressure
10%
Singapore
20%
Texas
10%
Titer
20%
Vaccine Effectiveness
10%
Vaccine Preparation
20%
Virus Isolation
10%
Immunology and Microbiology
Antibody Response
100%
Antigen
5%
Antigenicity
5%
Cross Reacting Antibody
5%
Hemagglutinin
100%
Infection
100%
Infectious Disease
100%
Influenza
11%
Influenza A Virus (H1N1)
100%
Influenza Vaccine
11%
Influenza Virus
100%
Titer
11%
Vaccine Efficacy
5%
Virus
16%
Virus Infection
5%
Virus Isolation
5%